The round was led by IVP, accelerating the company's mission to make advocacy a standard part of care for every patient in the United States. The Series C values Solace at over $1 billion and reflects growing consensus that healthcare advocacy is no longer optional as costs rise and systems fracture. The round also included participation from existing investors Menlo Ventures, SignalFire, Torch Capital, Inspired Capital and RiverPark Ventures.

Solace Health (Solace) is a digital platform that connects patients with expert healthcare advocates who navigate the healthcare system on their behalf, improving outcomes and reducing costs. Founded in 2022 by Jeremy Gurewitz and Sara Sargent after their own experiences with a fragmented healthcare system, Solace empowers patients to take control of their care journeys. Solace advocates coordinate appointments, manage treatment plans, and ensure continuity of care, helping patients and families overcome the obstacles that stand between them and better outcomes.